We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THR
2351
DELISTED
Thermon Group Holdings
THR
$719K ﹤0.01%
42,450
-104
-0.2% -$1.82K
ECVT icon
2352
Ecovyst
ECVT
$1.14B
$716K ﹤0.01%
69,880
-892
-1% -$9.76K
GRTS
2353
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$716K ﹤0.01%
55,695
+3,566
+7% +$39.5K
ORC
2354
Orchid Island Capital
ORC
$1.31B
$713K ﹤0.01%
31,685
+2,755
+10% +$66K
CVI icon
2355
CVR Energy
CVI
$3.13B
$711K ﹤0.01%
42,281
+760
+2% +$13.5K
MERC icon
2356
Mercer International
MERC
$39.8M
$711K ﹤0.01%
59,296
+3,161
+6% +$35K
HTB
2357
HomeTrust Bancshares
HTB
$848M
$711K ﹤0.01%
22,955
-383
-2% -$11.6K
AVO icon
2358
Mission Produce
AVO
$1.17B
$710K ﹤0.01%
45,215
+955
+2% +$17.8K
QUOT
2359
DELISTED
Quotient Technology Inc
QUOT
$707K ﹤0.01%
95,221
-1,490
-2% -$10.1K
GRWG icon
2360
GrowGeneration
GRWG
$90.7M
$706K ﹤0.01%
54,118
-903
-2% -$17.3K
WTBA icon
2361
West Bancorporation
WTBA
$485M
$701K ﹤0.01%
22,558
-291
-1% -$9.18K
IWP icon
2362
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$700K ﹤0.01%
6,076
+2,935
+93% +$342K
FLWS icon
2363
1-800-Flowers.com
FLWS
$258M
$698K ﹤0.01%
29,879
-44
-0.1% -$1.28K
KRON
2364
DELISTED
Kronos Bio
KRON
$698K ﹤0.01%
51,385
-604
-1% -$9.45K
SWIM icon
2365
Latham Group
SWIM
$880M
$695K ﹤0.01%
27,781
+8,452
+44% +$167K
PTVE
2366
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$695K ﹤0.01%
54,790
+1,697
+3% +$22.1K
NFE icon
2367
New Fortress Energy
NFE
$101M
$692K ﹤0.01%
28,659
-33
-0.1% -$914
TBPH icon
2368
Theravance Biopharma
TBPH
$877M
$691K ﹤0.01%
62,531
+1,682
+3% +$14.7K
MCRB icon
2369
Seres Therapeutics
MCRB
$48.4M
$689K ﹤0.01%
4,137
+59
+1% +$9.38K
MDXG icon
2370
MiMedx Group
MDXG
$633M
$689K ﹤0.01%
114,103
-1,932
-2% -$13.4K
EQBK icon
2371
Equity Bancshares
EQBK
$1.05B
$687K ﹤0.01%
20,240
-245
-1% -$8.27K
PRPL icon
2372
Purple Innovation
PRPL
$41.7M
$686K ﹤0.01%
2,069
+28
+1% +$10.8K
RBNC
2373
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$686K ﹤0.01%
19,338
-271
-1% -$9.22K
MSP
2374
DELISTED
Datto Holding Corp.
MSP
$685K ﹤0.01%
26,005
+1,291
+5% +$31.4K
CLAR icon
2375
Clarus
CLAR
$143M
$684K ﹤0.01%
24,667
+656
+3% +$18.1K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.